Myelodysplastic Syndromes (MDS) Clinical Trials

A listing of Myelodysplastic Syndromes (MDS) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Colorado

Denver Colorado 80218

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Connecticut

Hartford Connecticut 06105

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Florida

Tampa Florida 33602

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Maryland

Baltimore Maryland 21231

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Massachusetts

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Missouri

Kansas City Missouri 64128

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

New York

Bronx New York 10461

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Lake Success New York 11020

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

New York New York 10032

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

North Carolina

Winston-Salem North Carolina 27157

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

North Dakota

Ohio

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Tennessee

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Tyler Texas 75702

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Virginia

Norfolk Virginia 23502

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Washington

Yakima Washington 98902

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

West Virginia

West Virginia University - Clinical Trials Research Unit
Morgantown West Virginia 26506

E2905: Randomized Phase III Trial Comparing the frequency of Major Erythroid Response to Treatment with Lenolidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate 1 Risk MDS and Symptomatic Anemia

Argentina

Ciudad Autonoma Buenos Aires 1425

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ciudad Autonoma Buenos Aires 1114

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Santa Fe S3000ADL

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Australia

Adelaide South Australia 5000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Clayton Victoria 3168

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

East Melbourne Victoria 3002

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Kogarah New South Wales 2217

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Belgium

Brasschaat 2930

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Brugge 8000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Leuven 3000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Lodelinsart 6042

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Turnhout 2300

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Canada

Quebec Quebec G1J 1Z4

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Czech Republic

Brno 625 00

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ostrava 708 52

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Praha 10 100 34

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Praha 2 128 08

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Denmark

Aarhus 8000 C

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

France

Bobigny 93009

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Le Mans 72000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Lille 59037

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Nanes 44000

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Rouen 13273

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

View More ▼

Rouen Cedex 1 76038

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Toulouse 31059

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Germany

Dresden Sachsen 01307

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Duisburg Nordrhein-Westfalen 47166

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Frankfurt 60590

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Muenchen Bayern 81675

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Munster 48129

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)